Qiu Jiapei, Zhu Pengxiong, Liu Zixiong, Xu Hong, Liu Jun, Zhao Qiang
Department of Cardiac Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
VIP Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
J Thorac Dis. 2019 Jun;11(6):2402-2409. doi: 10.21037/jtd.2019.05.54.
This study sought to compare clinical outcomes of hybrid coronary revascularization (HCR) with off-pump coronary artery bypass grafting (OPCAB) and percutaneous coronary intervention (PCI) for the treatment of two-vessel coronary artery disease (CAD) including proximal LAD stenosis.
From January 2009 to December 2016, 52 patients of two-vessel CAD including proximal LAD stenosis underwent HCR at Rui Jin Hospital. Using propensity score methodology, these patients were matched with those in the OPCAB and PCI cohorts. The primary endpoint during follow-up was main adverse cardiovascular and cerebrovascular events (MACCE).
The intensive care unit (ICU) length of stay (LOS) and the hospital LOS were shorter in the HCR group than in the OPCAB group (ICU LOS: P<0.001; hospital LOS: P=0.027). The mean follow-up time was 59 months (interquartile range, 42 to 79 months). The 8-year freedom from MACCE of the HCR group was higher than that of the PCI group (P=0.008), but similar to that of the OPCAB group (P=0.893).
HCR provides favorable outcomes for selected patients with two-vessel CAD including proximal LAD stenosis.
本研究旨在比较杂交冠状动脉血运重建术(HCR)与非体外循环冠状动脉旁路移植术(OPCAB)及经皮冠状动脉介入治疗(PCI)治疗包括左前降支近端狭窄在内的双支冠状动脉疾病(CAD)的临床疗效。
2009年1月至2016年12月,52例包括左前降支近端狭窄的双支CAD患者在瑞金医院接受了HCR治疗。采用倾向评分法,将这些患者与OPCAB组和PCI组的患者进行匹配。随访期间的主要终点是主要不良心血管和脑血管事件(MACCE)。
HCR组的重症监护病房(ICU)住院时间(LOS)和住院总LOS均短于OPCAB组(ICU LOS:P<0.001;住院LOS:P=0.027)。平均随访时间为59个月(四分位间距,42至79个月)。HCR组8年无MACCE生存率高于PCI组(P=0.008),但与OPCAB组相似(P=0.893)。
对于选定的包括左前降支近端狭窄的双支CAD患者,HCR可提供良好的治疗效果。